0001558370-24-003118.txt : 20240313 0001558370-24-003118.hdr.sgml : 20240313 20240313170020 ACCESSION NUMBER: 0001558370-24-003118 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20240312 ITEM INFORMATION: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BIO-PATH HOLDINGS INC CENTRAL INDEX KEY: 0001133818 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 870652870 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-36333 FILM NUMBER: 24746817 BUSINESS ADDRESS: STREET 1: 4710 BELLAIRE BOULEVARD STREET 2: SUITE 210 CITY: BELLAIRE STATE: TX ZIP: 77401 BUSINESS PHONE: (832) 742-1357 MAIL ADDRESS: STREET 1: 4710 BELLAIRE BOULEVARD STREET 2: SUITE 210 CITY: BELLAIRE STATE: TX ZIP: 77401 FORMER COMPANY: FORMER CONFORMED NAME: OGDEN GOLF CO CORP DATE OF NAME CHANGE: 20010205 8-K 1 bpth-20240312x8k.htm 8-K
0001133818false00011338182024-03-122024-03-12

​

​

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

​

FORM 8-K

​

CURRENT REPORT PURSUANT

TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

​

Date of report (Date of earliest event reported): March 12, 2024

​

BIO-PATH HOLDINGS, INC.

(Exact name of registrant as specified in its charter)

​

​

​

Delaware

    

001-36333

    

87-0652870

(State or other jurisdiction of incorporation)

​

(Commission File Number)

​

(IRS Employer Identification No.)

​

​

​

4710 Bellaire Boulevard, Suite 210, Bellaire, Texas

    

77401

(Address of principal executive offices)

​

(Zip Code)

​

(832) 742-1357

(Registrant’s Telephone Number, Including Area Code)

​

(Former Name or Former Address, if Changed Since Last Report)

​

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

​

☐

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

​

Securities registered pursuant to Section 12(b) of the Act:

​

Title of each class

    

Trading Symbol

    

Name of each exchange on which registered

Common Stock, par value $0.001 per share

 

BPTH

 

The Nasdaq Capital Market

​

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

​

Emerging growth company ☐

​

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ◻

​

​

​

​

​

Item 3.01 Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing.

​

On March 12, 2024, Bio-Path Holdings, Inc. (the “Company”) received a deficiency letter (the “Letter”) from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that it is not in compliance with the minimum stockholders’ equity requirement of at least $2,500,000 for continued inclusion on The Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550(b)(1) (the “Stockholders’ Equity Requirement”). The Letter has no effect on the listing of the Company’s common stock at this time, and the Company’s common stock will continue to trade on The Nasdaq Capital Market under the symbol “BPTH.”

​

In accordance with Nasdaq Listing Rule 5810(c)(2)(A), the Company has 45 calendar days, or until April 26. 2024, to submit a plan to Nasdaq to regain compliance (the “Compliance Plan”) with the Stockholders’ Equity Requirement. If the Compliance Plan is accepted, Nasdaq can grant an extension of up to 180 days from the date of the Letter for the Company to evidence compliance. If the Compliance Plan is not accepted, Nasdaq could provide written notification to the Company that its common stock may be delisted. At that time, the Company may appeal Nasdaq’s delisting determination to a Nasdaq Hearings Panel (the “Panel”). If the Company timely appeals, it would remain listed pending the Panel’s decision. There can be no assurance that, if the Company does appeal the delisting determination by Nasdaq to the Panel, such appeal would be successful.

​

The Company is considering available options to regain compliance with the Stockholders’ Equity Requirement. However, there can be no assurance that the Company will be successful in developing the Compliance Plan, that the Compliance Plan will be accepted by Nasdaq, or even if it is accepted, that the Company will ultimately be able to regain compliance with the Stockholders’ Equity Requirement within the allotted extension period, which may be less than 180 calendar days.

​

​

​

​

​

SIGNATURES

​

Pursuant to the requirements of the Securities Exchange Act of 1934, the Company has duly caused this Current Report to be signed on its behalf by the undersigned hereunto duly authorized.

​

 

BIO-PATH HOLDINGS, INC.  

 

 

 

​

​

​

Dated: March 13, 2024

By:

/s/ Peter H. Nielsen

 

 

Peter H. Nielsen

 

 

President and Chief Executive Officer

​

​

 EX-101.SCH 2 bpth-20240312.xsd EX-101.SCH 00090 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 bpth-20240312_lab.xml EX-101.LAB EX-101.PRE 4 bpth-20240312_pre.xml EX-101.PRE XML 5 R1.htm IDEA: XBRL DOCUMENT v3.24.0.1
Document and Entity Information
Mar. 12, 2024
Document and Entity Information [Abstract]  
Document Type 8-K
Document Period End Date Mar. 12, 2024
Entity File Number 001-36333
Entity Registrant Name BIO-PATH HOLDINGS, INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 87-0652870
Entity Address State Or Province TX
Entity Address, Address Line One 4710 Bellaire Boulevard
Entity Address, Adress Line Two Suite 210
Entity Address, City or Town Bellaire
Entity Address, Postal Zip Code 77401
City Area Code 832
Local Phone Number 742-1357
Title of 12(b) Security Common Stock, par value $0.001 per share
Trading Symbol BPTH
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Entity Central Index Key 0001133818
Amendment Flag false
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.24.0.1 html 1 23 1 false 0 0 false 0 false false R1.htm 00090 - Document - Document and Entity Information Sheet http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false All Reports Book All Reports bpth-20240312.xsd bpth-20240312_lab.xml bpth-20240312_pre.xml bpth-20240312x8k.htm http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "bpth-20240312x8k.htm": { "nsprefix": "bpth", "nsuri": "http://www.biopathholdings.com/20240312", "dts": { "schema": { "local": [ "bpth-20240312.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "labelLink": { "local": [ "bpth-20240312_lab.xml" ] }, "presentationLink": { "local": [ "bpth-20240312_pre.xml" ] }, "inline": { "local": [ "bpth-20240312x8k.htm" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 0, "axisCustom": 0, "memberStandard": 0, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 1, "entityCount": 1, "segmentCount": 0, "elementCount": 24, "unitCount": 0, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 23 }, "report": { "R1": { "role": "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation", "longName": "00090 - Document - Document and Entity Information", "shortName": "Document and Entity Information", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "Duration_3_12_2024_To_3_12_2024_0xYhMMv-u0yJMvDJ7GM8HA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "bpth-20240312x8k.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "Duration_3_12_2024_To_3_12_2024_0xYhMMv-u0yJMvDJ7GM8HA", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "p", "div", "div", "body", "html" ], "reportCount": 1, "baseRef": "bpth-20240312x8k.htm", "first": true, "unique": true } } }, "tag": { "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "label": "Document and Entity Information [Abstract]", "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Adress Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Address State Or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r1" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r1" ] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r1" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r1" ] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r3" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r4" ] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r0" ] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r2" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r5" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://www.biopathholdings.com/role/DocumentDocumentAndEntityInformation" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" } } } ZIP 14 0001558370-24-003118-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001558370-24-003118-xbrl.zip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end XML 15 bpth-20240312x8k_htm.xml IDEA: XBRL DOCUMENT 0001133818 2024-03-12 2024-03-12 0001133818 false 8-K 2024-03-12 BIO-PATH HOLDINGS, INC. DE 001-36333 87-0652870 4710 Bellaire Boulevard Suite 210 Bellaire TX 77401 832 742-1357 false false false false Common Stock, par value $0.001 per share BPTH NASDAQ false